Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amlodipine besilate,atorvastatin calcium propylene glycol solvate -

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 10mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 10mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 20mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 20mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 40mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 40mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 80mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 80mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 10mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 10mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 20mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 20mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 40mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 40mg - hmg-coa reductase inhibitors

Canada - English - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 80mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 80mg - hmg-coa reductase inhibitors

United States - English - NLM (National Library of Medicine)

apotex corp. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10) - amlodipine 5 mg - amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with amlodipine and olmesartan medoxomil tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure